{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:53:38Z","timestamp":1790808818359,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000928","name":"Welch Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000928","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006988","name":"John S. Dunn Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006988","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.canlet.2019.09.013","type":"journal-article","created":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T19:22:37Z","timestamp":1569525757000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Antibiotic treatment ameliorates Ten-eleven translocation 2 (TET2) loss-of-function associated hematological malignancies"],"prefix":"10.1016","volume":"467","author":[{"given":"Hongxiang","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna G.","family":"Guzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengbing","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret A.","family":"Goodell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine Y.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deqiang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5950-9168","authenticated-orcid":false,"given":"Yun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.canlet.2019.09.013_bib1","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1056\/NEJMoa0810069","article-title":"Mutation in TET2 in myeloid cancers","volume":"360","author":"Delhommeau","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.canlet.2019.09.013_bib2","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1182\/blood-2012-02-408542","article-title":"Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters","volume":"120","author":"Lemonnier","year":"2012","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.canlet.2019.09.013_bib3","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1056\/NEJMc091348","article-title":"Mutation in TET2 in myeloid cancers","volume":"361","author":"Tefferi","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.canlet.2019.09.013_bib4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1056\/NEJMc1111708","article-title":"TET2 and DNMT3A mutations in human T-cell lymphoma","volume":"366","author":"Couronne","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"19","key":"10.1016\/j.canlet.2019.09.013_bib5","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1200\/JCO.2012.47.3314","article-title":"Prognostic score including gene mutations in chronic myelomonocytic leukemia","volume":"31","author":"Itzykson","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.canlet.2019.09.013_bib6","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/leu.2009.59","article-title":"Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS\/MPN and AML","volume":"23","author":"Tefferi","year":"2009","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.canlet.2019.09.013_bib7","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/leu.2011.10","article-title":"Molecular profiling of chronic myelomonocytic leukemia reveals diverse mutations in >80% of patients with TET2 and EZH2 being of high prognostic relevance","volume":"25","author":"Grossmann","year":"2011","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.canlet.2019.09.013_bib8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ccr.2011.06.003","article-title":"TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis","volume":"20","author":"Quivoron","year":"2011","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.canlet.2019.09.013_bib9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s12185-016-2122-z","article-title":"Dysregulation of TET2 in hematologic malignancies","volume":"105","author":"Chiba","year":"2017","journal-title":"Int. J. Hematol."},{"issue":"11","key":"10.1016\/j.canlet.2019.09.013_bib10","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/ng.2413","article-title":"Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis","volume":"44","author":"Busque","year":"2012","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.canlet.2019.09.013_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ccr.2011.06.001","article-title":"Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation","volume":"20","author":"Moran-Crusio","year":"2011","journal-title":"Cancer Cell"},{"issue":"35","key":"10.1016\/j.canlet.2019.09.013_bib12","doi-asserted-by":"crossref","first-page":"14566","DOI":"10.1073\/pnas.1112317108","article-title":"Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice","volume":"108","author":"Ko","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"17","key":"10.1016\/j.canlet.2019.09.013_bib13","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1182\/blood-2010-12-325241","article-title":"Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies","volume":"118","author":"Li","year":"2011","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.canlet.2019.09.013_bib14","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ng.3610","article-title":"DNMT3A and TET2 compete and cooperate to repress lineage-specific transcription factors in hematopoietic stem cells","volume":"48","author":"Zhang","year":"2016","journal-title":"Nat. Genet."},{"issue":"8","key":"10.1016\/j.canlet.2019.09.013_bib15","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1172\/JCI92026","article-title":"Mutations in 5-methylcytosine oxidase TET2 and RhoA cooperatively disrupt T cell homeostasis","volume":"127","author":"Zang","year":"2017","journal-title":"J. Clin. Investig."},{"issue":"4","key":"10.1016\/j.canlet.2019.09.013_bib16","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ccell.2015.03.009","article-title":"Mutational cooperativity linked to combinatorial epigenetic gain of function in acute myeloid leukemia","volume":"27","author":"Shih","year":"2015","journal-title":"Cancer Cell"},{"issue":"12","key":"10.1016\/j.canlet.2019.09.013_bib17","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1084\/jem.20131144","article-title":"Concurrent loss of Ezh2 and Tet2 cooperates in the pathogenesis of myelodysplastic disorders","volume":"210","author":"Muto","year":"2013","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.canlet.2019.09.013_bib18","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ccell.2018.01.001","article-title":"RHOA G17V induces T Follicular helper cell specification and promotes lymphomagenesis","volume":"33","author":"Cortes","year":"2018","journal-title":"Cancer Cell"},{"issue":"7706","key":"10.1016\/j.canlet.2019.09.013_bib19","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/s41586-018-0125-z","article-title":"Microbial signals drive pre-leukaemic myeloproliferation in a Tet2-deficient host","volume":"557","author":"Meisel","year":"2018","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.canlet.2019.09.013_bib20","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.stem.2018.10.013","article-title":"Inhibition of inflammatory signaling in Tet2 mutant preleukemic cells mitigates stress-induced abnormalities and clonal hematopoiesis","volume":"23","author":"Cai","year":"2018","journal-title":"Cell Stem Cell"},{"issue":"7","key":"10.1016\/j.canlet.2019.09.013_bib21","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/leu.2015.69","article-title":"Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes","volume":"29","author":"Ganan-Gomez","year":"2015","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.canlet.2019.09.013_bib22","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nri3062","article-title":"Inflammatory modulation of HSCs: viewing the HSC as a foundation for the immune response","volume":"11","author":"King","year":"2011","journal-title":"Nat. Rev. Immunol."},{"issue":"15","key":"10.1016\/j.canlet.2019.09.013_bib23","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1182\/blood-2017-06-780882","article-title":"Inflammation: a key regulator of hematopoietic stem cell fate in health and disease","volume":"130","author":"Pietras","year":"2017","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.canlet.2019.09.013_bib24","first-page":"603","article-title":"Risk factors for myelodysplastic syndromes: a case-control study in Greece","volume":"13","author":"Dalamaga","year":"2002","journal-title":"Cancer Causes Control"},{"issue":"4","key":"10.1016\/j.canlet.2019.09.013_bib25","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/MOH.0000000000000261","article-title":"The curious origins of angioimmunoblastic T-cell lymphoma","volume":"23","author":"Cortes","year":"2016","journal-title":"Curr. Opin. Hematol."},{"issue":"4","key":"10.1016\/j.canlet.2019.09.013_bib26","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.disamonth.2012.01.001","article-title":"Infections in hematological malignancies","volume":"58","author":"Khayr","year":"2012","journal-title":"Dis. Mon."},{"issue":"6","key":"10.1016\/j.canlet.2019.09.013_bib27","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1182\/blood-2016-03-708594","article-title":"Antibiotics impair murine hematopoiesis by depleting the intestinal microbiota","volume":"129","author":"Josefsdottir","year":"2017","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.canlet.2019.09.013_bib28","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1182\/blood-2018-02-832519","article-title":"Hematopoiesis and the bacterial microbiome","volume":"132","author":"Yan","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2019.09.013_bib29","doi-asserted-by":"crossref","first-page":"15102","DOI":"10.1038\/ncomms15102","article-title":"Tet2 loss leads to hypermutagenicity in haematopoietic stem\/progenitor cells","volume":"8","author":"Pan","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2019.09.013_bib30","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.exphem.2017.11.002","article-title":"An inflammatory environment containing TNFalpha favors Tet2-mutant clonal hematopoiesis","volume":"59","author":"Abegunde","year":"2018","journal-title":"Exp. Hematol."},{"issue":"1","key":"10.1016\/j.canlet.2019.09.013_bib31","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/ni.3630","article-title":"TET proteins regulate the lineage specification and TCR-mediated expansion of iNKT cells","volume":"18","author":"Tsagaratou","year":"2017","journal-title":"Nat. Immunol."},{"issue":"7447","key":"10.1016\/j.canlet.2019.09.013_bib32","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/nature12052","article-title":"Modulation of TET2 expression and 5-methylcytosine oxidation by the CXXC domain protein IDAX","volume":"497","author":"Ko","year":"2013","journal-title":"Nature"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383519304859?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383519304859?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T15:44:31Z","timestamp":1759592671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383519304859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":32,"alternative-id":["S0304383519304859"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2019.09.013","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibiotic treatment ameliorates Ten-eleven translocation 2 (TET2) loss-of-function associated hematological malignancies","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2019.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}